Novel types of C-3 substituted kynurenic acid derivatives with improved neuroprotective activity

Summary of the technology

Neurodegeneration may occur when the brain is exposed to high level of reactive oxygen species, mitochondrial dysfunction, neurotoxicity, such as excitotoxicity. Administering neuroprotective agents can prevent the chronic conditions damaging nerve cells. Therefore, there is an urgent need to develop effective neuroprotective agents.

University of Szeged

Details of the Technology Offer

The kynurenic acid (KYNA) is capable of interact with the metabolism of neurons and bearing neuroprotective properties. KYNA is a competitive antagonist of NMDA receptors on the neurons. Additionally, KYAN is able to affect the presynaptic release of glutamate via α7 nicotine acetylcholine receptors. Therefore, KYNA is capable to prevent neuron destruction caused by excitotoxic conditions.

According to its polar structure KYNA can penetrate through the blood-brain barrier (BBB) in a very low extent. The present invention solved the functionalization of the C-3 position of KYNA to prepare a compound that is able to penetrate through the BBB and bear effective neuroprotective properties. The C-3 substituted compounds of the invention are able to move through the BBB up to 7 times higher ratio than the currently existing KYNA compounds.

According to its polar structure KYNA can penetrate through the blood-brain barrier (BBB) in a very low extent. The present invention solved the functionalization of the C-3 position of KYNA to prepare a compound that is able to penetrate through the BBB and bear effective neuroprotective properties.

Desired business relationship

Patent licensing

Technology development

Intellectual property status

  • Granted Patent
  • Patent application number :EP3423444
  • Granted Patent
  • Patent application number :USA10870633

Related Keywords

  • Neurology, Brain Research
  • Medical Health related
  • Therapeutic
  • Other Medical/Health Related
  • Pharmaceuticals/fine chemicals
  • Clinical Medicine
  • neuroprotection

About University of Szeged

Top of the Hungarian University education; more than 21000 students, with about 4100 students from foreign countries; the highest level of reseach in Hungary; intellectual property portfolio of 41 patent, 8 know-how; numerous parts of the IP prtfolio is licenced or expoited in spin-off enterprises;

University of Szeged

Never miss an update from University of Szeged

Create your free account to connect with University of Szeged and thousands of other innovative organizations and professionals worldwide

University of Szeged

Send a request for information
to University of Szeged

About Technology Offers

Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.

Help

Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support